| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 02/07/2012 | CA2516514C Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 02/02/2012 | WO2012015723A1 Sulfonamide compounds useful as cyp17 inhibitors |
| 02/02/2012 | WO2012015168A2 Pharmaceutical composition comprising rosuvastatin or a pharmaceutically acceptable salt thereof |
| 02/02/2012 | WO2012014109A1 Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents |
| 02/02/2012 | WO2012013728A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 02/02/2012 | WO2012013727A1 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 02/02/2012 | WO2012013325A1 Process for the preparation of key intermediates for the synthesis of statins or pharmaceutically acceptable salts thereof |
| 02/02/2012 | WO2012013282A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 02/02/2012 | WO2011127388A3 Inverse agonists and neutral antagonists for the tsh receptor |
| 02/02/2012 | US20120029194 Liquid crystal compound having difluoropropenyleneoxy bonding group |
| 02/02/2012 | US20120029193 Polymerizable monomers |
| 02/02/2012 | US20120029000 Process for the preparation of alogliptin |
| 02/02/2012 | US20120028998 Co-crystal of etravirine and nicotinamide |
| 02/02/2012 | US20120028995 Novel compounds for medical use as peptidase effectors |
| 02/02/2012 | US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions |
| 02/02/2012 | US20120027857 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine |
| 02/02/2012 | US20120027733 Compositions to effect neuronal growth |
| 02/02/2012 | CA2806610A1 Bicyclic azaheterocyclic carboxamides as inhibitors of the kinase p70s6k |
| 02/02/2012 | CA2806008A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use |
| 02/01/2012 | EP2413192A1 Polymerizable monomers |
| 02/01/2012 | EP2412733A1 Polymer, chemically amplified negative resist composition, and patterning process |
| 02/01/2012 | EP2411373A1 Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof |
| 02/01/2012 | EP2411372A1 Process for preparing antiviral compound |
| 02/01/2012 | EP2411358A1 Leukotriene b4 inhibitors |
| 02/01/2012 | EP2411352A2 Antiviral compounds and uses thereof |
| 02/01/2012 | EP2410855A1 Process for the preparation of alogliptin |
| 02/01/2012 | CN102341376A 3-arylquinazolin-4-one compounds for combating invertebrate pests |
| 02/01/2012 | CN102341375A Pyrimidine derivatives and their use for controlling undesired plant growth |
| 02/01/2012 | CN102341372A Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 02/01/2012 | CN102336724A Novel cinepazide salt and its preparation method, and pharmaceutical composition based on cinepazide salt |
| 02/01/2012 | CN102336717A Quinazoline derivative |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102336679A 7-substituted tetracycline compounds |
| 02/01/2012 | CN101863842B 恩替卡韦中间体及合成方法 Entecavir intermediates and synthesis methods |
| 01/31/2012 | US8106213 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/31/2012 | US8106194 Pyrrolopyrimidine and pyrrolotriazine derivatives |
| 01/31/2012 | US8106063 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 01/31/2012 | CA2463989C Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof |
| 01/26/2012 | WO2012012528A1 Insecticidal triazines and pyrimidines |
| 01/26/2012 | WO2012011939A2 Synthesis of cyclopentaquinazolines |
| 01/26/2012 | WO2012011840A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 01/26/2012 | WO2012011592A1 Heterocyclic compound and application thereof |
| 01/26/2012 | WO2012011129A2 Novel polymorph of bis[(e)-7-[4-(4-fluorophenyl)-6-iso-propyl-2-[methyl (methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid] calcium salt |
| 01/26/2012 | WO2012010826A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 01/26/2012 | WO2012010316A1 Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/26/2012 | US20120023625 Chemical inhibitors of ethylene biosynthesis |
| 01/26/2012 | US20120022257 Processes for preparing hiv reverse transcriptase inhibitors |
| 01/26/2012 | US20120022256 Novel Hydrated Form of Erlotinib Free Base and a Process For Preparation Of Erlotinib Hydrochloride Polymorph Form A Substantially Free of Polymorph Form B |
| 01/26/2012 | US20120022091 Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof |
| 01/26/2012 | US20120022087 Amorphous ambrisentan |
| 01/26/2012 | US20120022074 Organic compounds |
| 01/26/2012 | US20120022070 Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use |
| 01/26/2012 | US20120022066 Insecticidal Triazines and Pyrimidines |
| 01/26/2012 | US20120022065 C-Met Modulators and Method of Use |
| 01/26/2012 | US20120021912 Novel herbicides |
| 01/26/2012 | US20120021909 Novel herbicides |
| 01/26/2012 | US20120021425 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 01/26/2012 | US20120018672 Liquid crystal compound, liquid crystal composition and liquid crystal display device |
| 01/26/2012 | CA2829046A1 Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 01/26/2012 | CA2806051A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anticancer agent, method for producing and using same |
| 01/26/2012 | CA2805567A1 Pyrimidine compounds as inhibitors of protein kinases ikk epsilon and/or tbk-1, processes for their preparation, and pharmaceutical compositions containing them |
| 01/26/2012 | CA2804889A1 Synthesis of cyclopentaquinazolines |
| 01/26/2012 | CA2803687A1 Insecticidal triazines and pyrimidines |
| 01/25/2012 | EP2409969A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/25/2012 | EP2408752A1 Substituted pyrimidines for the treatment of cancer |
| 01/25/2012 | EP2408744A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 01/25/2012 | EP2408454A2 Novel anti-inflammatory agents |
| 01/25/2012 | EP2408305A1 Pyrimindine-4-ylpropane dinitrile derivatives, method for the production thereof, and use thereof as herbicide and plant growth regulators |
| 01/25/2012 | EP1893587B1 Method for producing dihydroquinazolines |
| 01/25/2012 | EP1856063B1 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| 01/25/2012 | EP1797047B1 Hiv inhibiting 5-substituted pyrimidines |
| 01/25/2012 | EP1660458B1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 01/25/2012 | CN102333757A N-acyl anthranilic acid derivative or salt thereof |
| 01/25/2012 | CN101456841B Amide derivative and medicine |
| 01/24/2012 | US8101753 Production method of pyrimidine compounds |
| 01/24/2012 | US8101752 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino]benzonitrile |
| 01/24/2012 | US8101749 Process for the preparation of onium salts with a tetrafluoroborate anion having a reduced halide content |
| 01/24/2012 | US8101731 Yellow anionic disazo dyes |
| 01/24/2012 | US8101640 Antibacterial agents |
| 01/24/2012 | US8101637 Alkynyl derivatives as modulators of metatropic glutamate receptors |
| 01/24/2012 | US8101629 Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 01/24/2012 | US8101627 Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses |
| 01/24/2012 | US8101625 Pyrimidinones as Casein Kinase II (CK2) modulators |
| 01/24/2012 | US8101624 Quinazoline derivatives |
| 01/24/2012 | US8101621 Aminopyridine derivatives having aurora a selective inhibitory action |
| 01/24/2012 | US8101616 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 01/24/2012 | US8101615 Chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction, heart failure |
| 01/24/2012 | US8101588 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 01/24/2012 | CA2684447C Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/19/2012 | WO2012009699A2 Process for preparing antiviral compounds |
| 01/19/2012 | WO2012009097A1 Methods of treating lung disease |
| 01/19/2012 | WO2012008711A2 Erlotinib dichloroacetate and anti-cancer agent comprising the same |
| 01/19/2012 | WO2012008527A1 Pyrimidine compound and pest-control usage therefor |
| 01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
| 01/19/2012 | WO2012007861A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors |
| 01/19/2012 | WO2012007455A1 Process for the preparation of organic salts |
| 01/19/2012 | WO2012007365A1 1-hydroxyimino-3-phenyl-propanes |
| 01/19/2012 | WO2012006955A1 Compounds for treatment of metabolic disorders |
| 01/19/2012 | US20120015993 Novel Pharmaceutical Forms, and Methods of Making and Using the Same |